The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...

The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...

Though his condition had improved, he will remain in the hospital for further treatment, the Vatican said in a statement.

"Brensocatib has the potential to transform the treatment landscape for bronchiectasis and we were pleased to receive the FDA acceptance of our NDA with priority review even earlier than ...

Vatican City • Pope Francis has improved enough to no longer be considered in imminent danger from pneumonia and other ...

Despite significant advances in treatment in recent years ... which ideally have broad potential benefits for people with bronchiectasis and cystic fibrosis. We particularly welcome novel ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

"I sense that if the Lord does not help in this work of assisting the people of God to go forward, it can't be done." ...

The worst long-term complication of measles is a form of delayed encephalitis called subacute sclerosing panencephalitis ...

Electromed (NYSE:ELMD – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to ...